|
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, Lopez-Sendon J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE Jr, Rockhold FW, Broderick S, Ferguson TB Jr, Williams DO, Harrington RA, Stone GW, Rosenberg Y; ISCHEMIA Research Group. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30. PubMed PMID: 32227755; PubMed Central PMCID: PMC7263833.
AÑO: 2020; IF: 91.245
|
32227755
|
Tello-Montoliu A, Ruiz-Nodar JM, Esteve-Pastor MA, Veliz-Martinez A, Orenes-Pinero E, Macias-Villanego MJ, Lozano T, Carrillo-Aleman L, Vicente-Ibarra N, Pernias-Escrig V, Martinez-Martinez JG, Rivera-Caravaca JM, Marin F. Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year. J Clin Pharmacol. 2019 Feb;59(2):295-302. doi: 10.1002/jcph.1318. Epub 2018 Sep 12. PubMed PMID: 30207603.
AÑO: 2019; IF: 2.425
|
|
Rivera-Caravaca JM, Marin F, Esteve-Pastor MA, Galvez J, Lip GYH, Vicente V, Roldan V. Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation. BMJ Open. 2019 Dec 15;9(12):e033712. doi: 10.1136/bmjopen-2019-033712. Erratum In: BMJ Open. 2022 Dec 22;12(12):e033712corr1. PubMed PMID: 31843852; PubMed Central PMCID: PMC6924708.
AÑO: 2019; IF: 3.006
|
|
Rivera-Caravaca JM, Esteve-Pastor MA. Heart Failure and Cardiac Events: Is a Consecutive Measurement of Biomarkers a Simple and Practical Approach? Thromb Haemost. 2019 Dec;119(12):1891-1893. doi: 10.1055/s-0039-3400274. Epub 2019 Dec 5. No abstract available. PubMed PMID: 31805599.
AÑO: 2019; IF: 4.385
|
|
Rios SJ, Rivera-Caravaca JM, Aroca-Valverde C, Reguilon-Gallego L, Castillo-Rodriguez M, Esteve-Pastor MA, Vicente V, Marin F, Roldan V. Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists. QJM. 2019 Mar 1;112(3):183-188. doi: 10.1093/qjmed/hcy250. PubMed PMID: 30380132.
AÑO: 2019; IF: 2.529
|